Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05843500

Chronic Thromboembolic Disease Registry

Chronic Thromboembolic Disease: A Prospective Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main question\[s\] it aims to answer are: * Long-term outcome after various types of treatment, including medication, balloon pulmonary angioplasty, and pulmonary endarterectomy * Effect of treatment on patient's quality of life and exercise tolerance Participants will be followed longitudinally to assess their health outcomes and quality of life via chart review and health quality surveys.

Conditions

Interventions

TypeNameDescription
OTHERSurveyPatients who received medical, surgical or interventional treatment for chronic thromboembolic pulmonary hypertension will be followed and given quality of life questionnaires.

Timeline

Start date
2023-08-01
Primary completion
2028-07-01
Completion
2028-07-01
First posted
2023-05-06
Last updated
2025-06-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05843500. Inclusion in this directory is not an endorsement.